Laboratory Animals最新文献

For operant self-administration, permanent intravenous cannulas need to remain open and operational for months without infections or blockages. Here, we report retrospectively on our experiences and observations using different access systems during three studies. We identified a refined method for vena jugularis cannulation that is a vast improvement for the animals, biotechnicians and researchers. A closed and membrane-sealed system equipped with a magnet in the backmount was easy to use, allowed quick (dis)connection, caused no more than 10% of the animals a little irritation and superficial infection (softer patch), prevented clogging (closed system) and allowed for social housing (metal cap).

Assessing and alleviating pain in animals involved in research is critically important. However, the effective implementation of pain management depends on the knowledge and attitudes of the personnel involved. Following a Federation of European Laboratory Animal Science Associations 'Pain in Mice' working group initiative, a questionnaire to survey current practices concerning analgesic use in laboratory mice was distributed to several professional groups in the field of laboratory animal science. Besides demographic data, attitudes to pain and analgesia and sources of information and advice on pain management were assessed. Data were gathered and analysed through an e-survey provider. Most respondents (N = 222) were from Europe (90%). Analgesics were administered to murine surgical models by 92% of respondents in most cases and by 66% to all mice undergoing surgery. Most respondents used multimodal analgesic regimens (69%). For non-surgical models, 34% of respondents provided analgesics. The most commonly administered classes of analgesics were opioids (mostly buprenorphine) and non-steroidal anti-inflammatory drugs (mostly meloxicam and carprofen). A wide range of dose rates of meloxicam and carprofen was reported. Local anaesthetics were also widely used in surgical models (mostly lidocaine). Pain assessment was undertaken by most respondents (98%). In conclusion, most respondents provided analgesics to mice undergoing surgery and used analgesics in some non-surgical models. A considerable variation in the dose range used and the timing of administration of analgesics likely reflects both a lack of data and variation in pain assessment methodologies.

Diabetes mellitus, characterized by insufficient insulin secretion and impaired insulin efficacy, disrupts carbohydrate, protein, and lipid metabolism. The global diabetic population is expected to double by 2025, from 380 million, posing a significant health challenge. Most diabetic individuals fall into the type 1 or type 2 categories, and diabetes adversely affects various organs, such as the kidneys, liver, nervous system, reproductive system, and eyes.This review focuses on animal models of diabetes induced by chemical agents, which are essential tools for understanding disease mechanisms, investigating complications, and testing antidiabetic drugs. Models include those caused by streptozotocin (STZ), alloxan, ferric nitrilotriacetate (Fe-NTA), dithizone, and anti-insulin serum.Streptozotocin (STZ)-induced diabetes models create type 1 and 2 diabetes by destroying pancreatic beta cells. The combination of STZ with nicotinamide mimics type 2 diabetes phenotypes. Alloxan induces a hyperglycemic state by causing free radical formation that selectively destroys pancreatic beta cells. Fe-NTA and dithizone also create diabetes models by damaging pancreatic beta cells. Anti-insulin serum models induce insulin resistance and hyperglycemia by generating antibodies against insulin receptors, leading to a condition similar to type 1 diabetes.Each model has unique characteristics that make it suitable for different aspects of diabetes research. These models are used to understand the pathogenesis of diabetes, develop new treatment strategies, and evaluate the efficacy of potential drugs.

How do you promote ethical principles on a global scale regarding the use of animals for scientific purposes within a global pharmaceutical company like Sanofi? In 2017, the Advisory Body on Animal Ethics (ABAE) was created to harmonize animal ethics across all Sanofi sites. As an advisory body to the Bioethics Committee, the ABAE addresses societal concerns related to the use of animals and develops corporate policies on critical topics. Its composition, objectives and operating processes are described, along with the results achieved. Emphasis is placed on responsibilities, training and the promotion of a culture of care. The existence of an advisory body such as the ABAE can be replicated in other institutions to demonstrate commitment to an ethical approach to the use of animals worldwide.

This study investigated the effectiveness of combining cloprostenol (Cl) and progesterone (Pg) injections for oestrous synchronization in female rats. A comprehensive series of experiments was conducted to explore the impact of hormonal injections on subsequent reproductive behaviour. The study involved dividing rats into distinct groups, with each group subjected to specific injections of either Cl, Pg, or their combinations. We observed a 100% conception efficiency within the first day after the last Cl injection in the Cl + Pg + Cl group. This finding underscores the remarkable effectiveness of the employed protocol, resulting in a rapid initiation of pregnancy in a substantial number of female rats on the same day.

For over 40 years, ivermectin has served as an effective anti-parasitic drug used in human and veterinary medicine. In laboratory animal facilities it is used prophylactically or therapeutically to maintain the health status of the colony or experimentally in studies. Although ivermectin is generally safe to use, there are reports of neurotoxicity associated with ivermectin crossing the blood-brain barrier due to overdosing or blood-brain barrier dysfunction. In mice, P-glycoprotein maintains the blood-brain barrier and mice with a mutation in the P-glycoprotein encoding gene mdr1a are 50-100 times more sensitive to ivermectin. Signs of neurotoxicity include ataxia, bradypnea, recumbency, tremor, and death. We report neurotoxicity after ivermectin administration was used for the purpose of eradicating the murine-specific intestinal nematode Heligmosomoides polygyrus in C57BL/6NTac and C57BL/6NCrl mice. The mice were dewormed by subcutaneous administration of 10 or 20 mg/kg ivermectin to eradicate all stages of Heligmosomoides polygyrus. At 24-48h after deworming, 5% (n = 4) of the mice presented with tremor, ataxia, and/or head tilt. The affected mice were euthanised and gross pathological findings were found in one of the four mice (left-sided hydronephrosis). We assume that the observed neurological effects were due to defects in the blood-brain barrier, overdosing or individual sensitivity. This report provides a reason for caution when deworming laboratory mice subcutaneously with ivermectin at doses of 10 mg/kg or higher.

Blood sampling is often performed during animal studies. This is more challenging in mice than in larger animal species owing to their size and lack of blood vessel visibility. Guidelines for blood sampling in mice and papers on animal welfare often refer to the submandibular, cheek, buccal, and anterior facial veins. However, these terms are imprecise. There are at least two different superficial veins that can be used for blood sampling on the head of the mouse; moreover, most studies ignore this distinction. Inaccurate descriptions and even incorrect labelling of the images lead to confusion and unnecessary delays in learning blood collection techniques, as well as stress and pain in animals due to failed attempts. This review explains the most common terminological errors, demonstrates the distinction between bleeding facial and superficial temporal veins using original photographs, and discusses the suitability of sampling from both veins.